Novel blood-based method diagnoses Alzheimer’s disease with high accuracy
Alzheimer’s disease (AD) accounts for 60–80% of global dementia cases, with its core pathological feature being the misfolding and aggregation of β-amyloid (Aβ) proteins in the brain.